February 22, 2024Open Access

Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose (18FFDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer

Key Points

Key points are not available for this paper at this time.

Abstract

Programmed death-ligand 1 (PD-L1) expression is a predictive biomarker for immunotherapy in non-small cell lung cancer (NSCLC). PD-L1 and glucose transporter 1 expression are closely associated, and studies demonstrate correlation of PD-L1 with glucose metabolism.

Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose (18FFDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer

Key Points

Abstract

Cite This Study

Also Consider

Also Consider